Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Xiang-Lin TanJian-Yu EYong LinTimothy R RebbeckShou-En LuMingyi ShangWilliam K KellyAnthony D'AmicoMark N SteinLanjing ZhangThomas L JangIsaac Yi KimKitaw DemissieAnna FerrariGrace L Lu-YaoPublished in: Cancer medicine (2020)
Statin use alone or in combination with metformin was associated with lower all-cause and PCa mortality among high-risk patients, particularly in post-diagnostic settings; further studies are warranted.